Hyderabad, Apr 8 (UNI) Arkray Inc., Japan-based makers of the world's first-ever diabetes self-monitoring device, in partnership with Piramal Healthcare, has launched Glucocard 01, a highly-advanced glucometer.
Glucocard 01 offered a high level of accuracy and precision in self-monitoring of blood glucose due to the use of sophisticated and unique biosensor technology. In addition, Glucocard 01 ensured a virtually pain-free testing experience for the diabetic patient, according to a release here.
Biosensor technology was accepted as superior, since its accuracy and precision were far greater than that obtained with photometer technology, commonly used in other glucometers.
''Our commitment towards diabetes care goes back to 1970, when we developed the world's first self-monitoring blood glucose meter (Eyetone)...We are continually committed to developing products that improve the quality of life of diabetes patients. Glucocard 01 offers a high level of accuracy and precision and hence will provide better self-monitoring options to the patients,'' Arkray Piramal Medical Pvt Ltd Chairman Hidehiro Itokawa said.
Glucocard 01 used a unique combination of a Ruthenium-based mediator and thin film, carbon-coated electrodes, which made the testing strips (all glucometers require disposable testing strips) free from temperature and humidity interference, thus ensuring accurate and precise results.
In addition, the new glucometer provided automatic calibration (minimising chances of manual errors) and a temperature compensation mechanism (using an in-built thermistor). As the blood sample required for testing was minimal (0.3 microlitres) for Glucocard 01, this ensured a virtually error-free and pain-free testing experience for the patient.
UNI VA GD SM1710